» Articles » PMID: 12950377

The Prevalence and Disability Burden of Adult Migraine in England and Their Relationships to Age, Gender and Ethnicity

Overview
Journal Cephalalgia
Specialties Neurology
Psychiatry
Date 2003 Sep 3
PMID 12950377
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

This study estimates the 1-year prevalence of migraine in adults in England in relation to the major demographic variables of age, gender and ethnicity, and describes some of its features, including aspects of consequential disability. A telephone survey was conducted of a random sample (n = 4007) of the population aged 16-65 years of mainland England using a previously validated diagnostic interview. The response rate was 76.5%. Overall, 7.6% of males and 18.3% of females reported migraine with or without aura within the last year meeting diagnostic criteria closely approximate to those of the International Headache Society. Prevalence of migraine varied with age, rising through early adult life and declining in the late 40s and early 50s. Prevalence was higher in Caucasians than in other races. Attack rates were > or = 1/month in most migraineurs, and most experienced interference with daily activities in > or = 50% of their attacks. On average, an estimated 5.7 working days were lost per year for every working or student migraineur, although the most disabled 10% accounted for 85% of the total. Results were in keeping with those from surveys in other countries. If these findings in mainland England are projected to the entire UK population, we estimate that 5.85 million people aged 16-65 years experience 190 000 migraine attacks every day and lose 25 million days from work or school each year because of them. Migraine is an important public health problem in the UK, associated with very substantial costs.

Citing Articles

Migraine in men.

Fitzek M, Boucherie D, de Vries T, Handtmann C, Fathi H, Raffaelli B J Headache Pain. 2025; 26(1):3.

PMID: 39754046 PMC: 11697684. DOI: 10.1186/s10194-024-01936-7.


Orofacial Migraine-A Narrative Review.

Benoliel R, May A J Clin Med. 2024; 13(19).

PMID: 39407805 PMC: 11476786. DOI: 10.3390/jcm13195745.


Health-related quality of life among women and men living with migraine: a Canada-wide cross-sectional study.

Tam A, Naik H, Trenaman L, Lynd L, Zhang W J Headache Pain. 2024; 25(1):170.

PMID: 39379822 PMC: 11462961. DOI: 10.1186/s10194-024-01882-4.


Household income is associated with attack frequency, but not with the prevalence of headache: an analysis of self-reported headache in the general population in Germany.

Muller B, Gaul C, Reis O, Jurgens T, Kropp P, Ruscheweyh R J Headache Pain. 2024; 25(1):164.

PMID: 39354353 PMC: 11443947. DOI: 10.1186/s10194-024-01844-w.


An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.

Griffin E, Shirley G, Lee X, Awad S, Tyagi A, Goadsby P J Headache Pain. 2024; 25(1):59.

PMID: 38637754 PMC: 11027549. DOI: 10.1186/s10194-024-01749-8.